Evidence map›Paper›PMID 19654105›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2009

Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.

J Scott Brockenbrough, Janice K Morihara, Stephen E Hawes, Joshua E Stern, Janet S Rasey, Linda W Wiens, Qinghua Feng, Hubert Vesselle

Open access · bronzeAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Evaluation of [Molecular imaging and biology · 2017
    Article
  5. Thymidine Phosphorylase in Cancer; Enemy or Friend?Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2016
    Review
  6. Article
  7. Article
  8. Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung.International journal of clinical and experimental medicine · 2014
    Article
  9. Article
  10. High thymidine kinase 1 (TK1) expression is a predictor of poor survival in patients with pT1 of lung adenocarcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2012
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

J Scott Brockenbrough, Division of Nuclear Medicine, Department of Radiology, University of Washington Medical Center, Seattle, WA 98195-7115, USA.
Janice K Morihara
Stephen E Hawes
Joshua E Stern
Janet S Rasey
Linda W Wiens
Qinghua Feng
Hubert Vesselle
University of Washington · US

Funding

Lung Cancer Prognosis: FLT PET and DNA HypermethylationR01CA115559 · NCI · UNIVERSITY OF WASHINGTON · PI VESSELLE, HUBERT J · 2005 to 2009
$2.7M
FLT PET to Plan the Best Therapy for Lung CancerR01CA107264 · NCI · UNIVERSITY OF WASHINGTON · PI VESSELLE, HUBERT J · 2004 to 2008
$2.0M
NCI NIH HHS CA-107264NCI NIH HHS CA-115559NCI NIH HHS R01 CA107264NCI NIH HHS R01 CA115559
6 · The paper itself

Abstract

The thymidine salvage pathway enzymes thymidine kinase 1 (TK1) and thymidine phosphorylase (TP) compete for thymidine as a substrate and catalyze opposing synthetic and catabolic reactions that have been implicated in the control of proliferation and angiogenesis, respectively. We investigated the relationship between the expression of TK1 and TP as they relate to proliferation (Ki-67 labeling index) and angiogenesis (Chalkley count of CD31-stained blood vessels) in a series of 110 non-small-cell lung cancer (NSCLC) tumors from patients prospectively enrolled in an imaging trial. TK1 and TP exhibited similar patterns of immunohistochemical distribution, in that each was found in both the nucleus and the cytoplasm of tumor cells. Each enzyme exhibited a significant positive correlation between its levels of nuclear and cytoplasmic expression. A significant positive correlation between TK1 expression and the Ki-67 labeling index (r = 0.53, p<0.001) was observed. TP was significantly positively correlated with Chalkley scoring of CD31 staining in high vs low Chalkley scoring samples (mean TP staining of 115.8 vs 79.9 scoring units, p<0.001), respectively. We did not observe a substantial inverse correlation between the TP and TK1 expression levels in the nuclear compartment (r = -0.17, p=0.08). Tumor size was not found to be associated with TK1, TP, Ki-67, or Chalkley score. These findings provide additional evidence for the role of thymidine metabolism in the complex interaction of proliferation and angiogenesis in NSCLC.

Indexed as

Gene Expression Regulation, NeoplasticAgedCarcinoma, Non-Small-Cell LungCell NucleusCell ProliferationClinical Trials as TopicCytoplasmFemaleHumansImmunohistochemistryKi-67 AntigenLung NeoplasmsMaleMiddle AgedNeovascularization, PathologicStaining and LabelingKi-67 AntigenThymidine Kinasethymidine kinase 1Thymidine Phosphorylase

Identifiers

PMID19654105
PMCPMC2762886
OpenAlexW2121390208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.